2019 - Fellow of the Royal Society of Edinburgh
Stephen J. Wigmore focuses on Internal medicine, Surgery, Gastroenterology, Cachexia and Endocrinology. Stephen J. Wigmore combines subjects such as Incidence and Confidence interval with his study of Surgery. His Gastroenterology research is multidisciplinary, incorporating elements of Body mass index, Multiple organ dysfunction syndrome, Systemic inflammatory response syndrome, Palliative care and Performance status.
His work in Cachexia addresses issues such as Urine, which are connected to fields such as Protein degradation, Antigen, Proteinuria and Monoclonal antibody. The concepts of his Endocrinology study are interwoven with issues in Oxidative phosphorylation, Angiogenesis and Downregulation and upregulation. His Pancreas research focuses on subjects like Cancer, which are linked to Cytokine.
Stephen J. Wigmore mostly deals with Surgery, Internal medicine, Liver transplantation, Transplantation and Gastroenterology. His study explores the link between Surgery and topics such as Anesthesia that cross with problems in Randomized controlled trial. His study looks at the relationship between Internal medicine and topics such as Endocrinology, which overlap with Acute-phase protein.
In his study, Immunology is strongly linked to Reperfusion injury, which falls under the umbrella field of Transplantation. His research on Gastroenterology often connects related topics like Incidence. His Pancreatic cancer research is multidisciplinary, relying on both Pancreatic disease and Pancreas.
His scientific interests lie mostly in Internal medicine, Liver transplantation, Gastroenterology, Surgery and MEDLINE. His work on Internal medicine is being expanded to include thematically relevant topics such as Oncology. His Liver transplantation research includes themes of Hepatocellular carcinoma, Propensity score matching and Retrospective cohort study.
His work carried out in the field of Gastroenterology brings together such families of science as Incidence, Time trends and Patient population. Stephen J. Wigmore usually deals with Surgery and limits it to topics linked to Liver function tests and Cirrhosis. His biological study spans a wide range of topics, including Cardiothoracic surgery, Cardiac surgery, Vascular surgery, Prehabilitation and Intensive care medicine.
Stephen J. Wigmore mainly focuses on Internal medicine, Liver transplantation, Fibrosis, Transplantation and Gastroenterology. His study ties his expertise on Cardiothoracic surgery together with the subject of Internal medicine. His Liver transplantation study combines topics from a wide range of disciplines, such as Liver disease, Hepatocellular carcinoma and Patient population.
The Fibrosis study combines topics in areas such as Liver function, Lobules of liver, Hepatic stellate cell, Mesenchyme and Liver injury. His Transplantation research incorporates elements of Review article, Randomized controlled trial, Perfusion and Intensive care medicine. His Gastroenterology research integrates issues from Biliary surgery, Incidence, Time trends and Disease epidemiology.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Association between early systemic inflammatory response, severity of multiorgan dysfunction and death in acute pancreatitis
R Mofidi;M D Duff;S J Wigmore;K K Madhavan.
British Journal of Surgery (2006)
The value of residual liver volume as a predictor of hepatic dysfunction and infection after major liver resection
M J Schindl;D N Redhead;K C H Fearon;O J Garden.
Gut (2005)
The effect of polyunsaturated fatty acids on the progress of cachexia in patients with pancreatic cancer.
Stephen J. Wigmore;James A. Ross;J. Stuart Falconer;Claire E. Plester.
Nutrition (1996)
Negative Regulation of Soluble Flt-1 and Soluble Endoglin Release by Heme Oxygenase-1
Melissa Cudmore;Shakil Ahmad;Bahjat Al-Ani;Takeshi Fujisawa.
Circulation (2007)
Human primary liver cancer–derived organoid cultures for disease modeling and drug screening
Laura Broutier;Gianmarco Mastrogiovanni;Monique M.A. Verstegen;Hayley E. Francies.
Nature Medicine (2017)
Acute-phase protein response and survival duration of patients with pancreatic cancer.
J. S. Falconer;K. C. H. Fearon;J. A. Ross;R. Elton.
Cancer (1995)
Systemic inflammation, cachexia and prognosis in patients with cancer.
Christopher Deans;Stephen J Wigmore.
Current Opinion in Clinical Nutrition and Metabolic Care (2005)
Effect of oral eicosapentaenoic acid on weight loss in patients with pancreatic cancer.
Stephen J. Wigmore;Matthew D. Barber;James A. Ross;Michael J. Tisdale.
Nutrition and Cancer (2000)
Management of biliary tract complications after orthotopic liver transplantation.
Sanjeet Thethy;Benjamin N. J. Thomson;Henry Pleass;Stephen J. Wigmore.
Clinical Transplantation (2004)
Changes in nutritional status associated with unresectable pancreatic cancer
S. J. Wigmore;C. E. Plester;R. A. Richardson;K. C. H. Fearon.
British Journal of Cancer (1997)
HPB
(Impact Factor: 3.842)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:
University of Edinburgh
Queen Elizabeth Hospital Birmingham
University of Edinburgh
Maastricht University
University of Edinburgh
Wellcome Sanger Institute
Stavanger University Hospital
European Bioinformatics Institute
Aston University
University of Glasgow
Max Planck Society
Tokyo Institute of Technology
The Wistar Institute
University of Helsinki
Harvard Medical School
RIKEN
University of Kentucky
Technical University of Darmstadt
Brown University
University of Tokyo
University of Cagliari
Washington University in St. Louis
University of Wisconsin–Madison
University of Iowa
Pennsylvania State University
University of Oxford